Frontlight ResearchEarly access
Trial site
Changzhou First People's Hospital
- 12running trials
- 3closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer3 trials
- Atopic dermatitis (eczema)2 trials
- Acute myeloid leukaemia1 trial
- Bronchiectasis1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- IgA nephropathy1 trial
- Lung cancer1 trial
- Migraine1 trial
- Obesity1 trial
- Psoriasis1 trial
- Vitiligo1 trial
- Phase
- Phase 37 trials
- Phase 23 trials
- Phase 2/32 trials
- Status
- Not yet recruiting5 trials
- Recruiting4 trials
- Active, not recruiting3 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.3 trials
- Hoffmann-La Roche3 trials
- Antengene Biologics Limited1 trial
- Beijing Tiantan Hospital1 trial
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Active, not recruiting
The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)
Recruiting
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Bronchiectasis1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Lung cancer1 recruiting
- Migraine1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 13 Nov 2026